Genpact (G) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Genpact Revenue Highlights

Latest Revenue (Y)

$4.48B

Latest Revenue (Q)

$1.21B

Main Segment (Y)

Consumer Goods Retail Life Sciences And Healthcare

Main Geography (Y)

INDIA

Genpact Revenue by Period

Genpact Revenue by Year

Date	Revenue	Change
2023-12-31	$4.48B	2.42%
2022-12-31	$4.37B	8.68%
2021-12-31	$4.02B	8.43%
2020-12-31	$3.71B	5.36%
2019-12-31	$3.52B	17.32%
2018-12-31	$3.00B	9.64%
2017-12-31	$2.74B	6.46%
2016-12-31	$2.57B	4.46%
2015-12-31	$2.46B	7.97%
2014-12-31	$2.28B	6.92%
2013-12-31	$2.13B	12.09%
2012-12-31	$1.90B	18.84%
2011-12-31	$1.60B	27.12%
2010-12-31	$1.26B	12.40%
2009-12-31	$1.12B	7.61%
2008-12-31	$1.04B	26.52%
2007-12-31	$822.68M	34.20%
2006-12-31	$613.05M	24.63%
2005-12-31	$491.89M	66.74%
2002-12-31	$295.00M	-

Genpact generated $4.48B in revenue during NA 2023, up 2.42% compared to the previous quarter, and up 149.19% compared to the same period a year ago.

Genpact Revenue by Quarter

Date	Revenue	Change
2024-09-30	$1.21B	3.08%
2024-06-30	$1.18B	3.97%
2024-03-31	$1.13B	-1.34%
2023-12-31	$1.15B	0.92%
2023-09-30	$1.14B	2.74%
2023-06-30	$1.11B	1.49%
2023-03-31	$1.09B	-1.20%
2022-12-31	$1.10B	-0.76%
2022-09-30	$1.11B	2.01%
2022-06-30	$1.09B	1.94%
2022-03-31	$1.07B	-0.36%
2021-12-31	$1.07B	5.57%
2021-09-30	$1.02B	2.79%
2021-06-30	$988.13M	4.45%
2021-03-31	$946.07M	-0.47%
2020-12-31	$950.57M	1.61%
2020-09-30	$935.52M	3.94%
2020-06-30	$900.09M	-2.50%
2020-03-31	$923.19M	-1.87%
2019-12-31	$940.74M	5.84%
2019-09-30	$888.80M	0.79%
2019-06-30	$881.80M	8.97%
2019-03-31	$809.21M	-3.13%
2018-12-31	$835.34M	11.68%
2018-09-30	$747.98M	2.67%
2018-06-30	$728.56M	5.76%
2018-03-31	$688.91M	-6.20%
2017-12-31	$734.41M	3.61%
2017-09-30	$708.82M	5.68%
2017-06-30	$670.70M	7.66%
2017-03-31	$623.00M	-8.62%
2016-12-31	$681.75M	5.08%
2016-09-30	$648.78M	2.90%
2016-06-30	$630.52M	3.41%
2016-03-31	$609.70M	-5.70%
2015-12-31	$646.53M	4.64%
2015-09-30	$617.83M	1.36%
2015-06-30	$609.53M	3.81%
2015-03-31	$587.15M	-2.39%
2014-12-31	$601.53M	2.28%
2014-09-30	$588.11M	4.72%
2014-06-30	$561.61M	6.33%
2014-03-31	$528.19M	-5.42%
2013-12-31	$558.46M	4.41%
2013-09-30	$534.89M	0.02%
2013-06-30	$534.80M	6.14%
2013-03-31	$503.85M	-0.76%
2012-12-31	$507.70M	3.37%
2012-09-30	$491.16M	5.03%
2012-06-30	$467.63M	7.38%
2012-03-31	$435.48M	-1.63%
2011-12-31	$442.69M	3.06%
2011-09-30	$429.56M	8.03%
2011-06-30	$397.62M	20.29%
2011-03-31	$330.55M	-3.22%
2010-12-31	$341.55M	6.21%
2010-09-30	$321.57M	4.53%
2010-06-30	$307.63M	6.73%
2010-03-31	$288.22M	-2.94%
2009-12-31	$296.95M	4.40%
2009-09-30	$284.44M	4.25%
2009-06-30	$272.85M	2.64%
2009-03-31	$265.83M	-5.68%
2008-12-31	$281.85M	4.08%
2008-09-30	$270.80M	6.79%
2008-06-30	$253.58M	8.17%
2008-03-31	$234.43M	1.20%
2007-12-31	$231.65M	-

Genpact generated $1.21B in revenue during Q3 2024, up 3.08% compared to the previous quarter, and up 109.62% compared to the same period a year ago.

Genpact Revenue Breakdown

Genpact Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 21	Dec 19	Dec 18
Consumer Goods Retail Life Sciences And Healthcare	$1.51B	-	-
High Tech Manufacturing And Services	$1.48B	-	-
Banking Capital Markets And Insurance	$1.02B	-	-
Business Process Services	-	$2.97B	$2.50B
Information Technology Services	-	$546.33M	$497.98M

Genpact's latest annual revenue breakdown by segment (product or service), as of Dec 21: Consumer Goods Retail Life Sciences And Healthcare (37.69%), High Tech Manufacturing And Services (36.93%), and Banking Capital Markets And Insurance (25.38%).

Quarterly Revenue by Product

Product/Service	Mar 22	Dec 21	Sep 21	Jun 21	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Consumer Goods Retail Life Sciences And Healthcare	$404.18M	$408.35M	$388.07M	$373.08M	-	-	-	-	-	-	-	-
Banking Capital Markets And Insurance	$276.16M	$266.20M	$258.52M	$249.76M	-	-	-	-	-	-	-	-
High Tech Manufacturing And Services	$394.95M	$397.39M	$366.74M	$358.10M	-	-	-	-	-	-	-	-
Other Segments	-	-	-	$7.19M	-	-	-	-	-	-	-	-
Information Technology Services	-	-	-	-	$140.09M	$139.48M	$138.82M	$127.94M	$135.44M	$125.04M	$122.65M	$114.85M
Business Process Services	-	-	-	-	$800.65M	$749.32M	$742.98M	$681.26M	$699.89M	$622.94M	$605.91M	$574.06M

Genpact's latest quarterly revenue breakdown by segment (product or service), as of Mar 22: Consumer Goods Retail Life Sciences And Healthcare (37.59%), High Tech Manufacturing And Services (36.73%), and Banking Capital Markets And Insurance (25.68%).

Genpact Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Asia Other Than India	$643.10M	$551.47M	$536.60M	$461.84M	$356.73M
Americas	$979.95M	$1.07B	$1.01B	$1.01B	$863.75M
Europe	$532.99M	$471.48M	$451.73M	$388.56M	$409.17M
INDIA	$2.32B	$2.28B	$2.02B	$1.85B	$1.89B

Genpact's latest annual revenue breakdown by geography, as of Dec 23: INDIA (51.84%), Americas (21.89%), Asia Other Than India (14.36%), and Europe (11.91%).

Quarterly Revenue by Country

Country	Mar 22	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
High Tech Manufacturing And Services	$394.95M	-	-	-	-	-	-	-	-
Consumer Goods Retail Life Sciences And Healthcare	$404.18M	-	-	-	-	-	-	-	-
Banking Capital Markets And Insurance	$276.16M	-	-	-	-	-	-	-	-
Americas	-	$240.88M	$233.06M	$208.05M	$181.76M	$185.47M	$152.12M	$151.84M	$152.28M
Asia Other Than India	-	$95.26M	$86.01M	$81.79M	$93.66M	$85.93M	$83.84M	$78.23M	$79.46M
INDIA	-	$494.91M	$472.90M	$486.35M	$436.74M	$477.23M	$408.17M	$464.92M	$389.13M
Europe	-	$109.69M	$96.83M	$105.61M	$97.04M	$86.71M	$103.84M	$33.57M	$68.04M

Genpact's latest quarterly revenue breakdown by geography, as of Mar 22: Consumer Goods Retail Life Sciences And Healthcare (37.59%), High Tech Manufacturing And Services (36.73%), and Banking Capital Markets And Insurance (25.68%).

Genpact Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CDW	CDW	$21.38B	$5.52B
CACI	CACI	$7.66B	$2.06B
SAIC	Science Applications	$7.44B	$1.82B
BR	Broadridge Financial Solutions	$6.51B	$1.42B
G	Genpact	$4.48B	$1.21B
ASGN	ASGN	$4.45B	$1.03B
CLVT	Clarivate	$2.63B	$622.20M
TTEC	TTEC	$2.46B	$529.43M
JKHY	Jack Henry & Associates	$2.20B	$600.98M
EXLS	ExlService	$1.63B	$472.07M
WNS	WNS	$1.32B	$322.60M
TWKS	Thoughtworks	$1.13B	$251.67M
PRFT	Perficient	$906.54M	$215.30M

G Revenue FAQ

What is Genpact’s yearly revenue?

Genpact's yearly revenue for 2023 was $4.48B, representing an increase of 2.42% compared to 2022. The company's yearly revenue for 2022 was $4.37B, representing an increase of 8.68% compared to 2021. G's yearly revenue for 2021 was $4.02B, representing an increase of 8.43% compared to 2020.

What is Genpact’s quarterly revenue?

Genpact's quarterly revenue for Q3 2024 was $1.21B, a 3.08% increase from the previous quarter (Q2 2024), and a 6.70% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.18B, a 3.97% increase from the previous quarter (Q1 2024), and a 6.35% increase year-over-year (Q2 2023). G's quarterly revenue for Q1 2024 was $1.13B, a -1.34% decrease from the previous quarter (Q4 2023), and a 3.81% increase year-over-year (Q1 2023).

What is Genpact’s revenue growth rate?

Genpact's revenue growth rate for the last 3 years (2021-2023) was 11.30%, and for the last 5 years (2019-2023) was 27.16%.

What are Genpact’s revenue streams?

Genpact's revenue streams in c 21 are Consumer Goods Retail Life Sciences And Healthcare, High Tech Manufacturing And Services, and Banking Capital Markets And Insurance. Consumer Goods Retail Life Sciences And Healthcare generated $1.51B in revenue, accounting 37.69% of the company's total revenue High Tech Manufacturing And Services generated $1.48B in revenue, accounting 36.93% of the company's total revenue Banking Capital Markets And Insurance generated $1.02B in revenue, accounting 25.38% of the company's total revenue

What is Genpact’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Genpact was Consumer Goods Retail Life Sciences And Healthcare. This segment made a revenue of $1.51B, representing 37.69% of the company's total revenue.